TrialEuropean journal of clinical pharmacology2005

Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity.

T Fukasawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.